Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases).

MLA

Domain, Roxane, et al. “Pharmacological Inhibition of Cathepsin S and of NSPs-AAP-1 (a Novel, Alternative Protease Driving the Activation of Neutrophil Serine Proteases).” Biochemical Pharmacology, vol. 229, Nov. 2024, p. 116114. EBSCOhost, https://doi.org/10.1016/j.bcp.2024.116114.

APA

Domain, R., Seren, S., Jerke, U., Makridakis, M., Chen, K.-J., Zoidakis, J., Rhimi, M., Zhang, X., Bonvent, T., Croix, C., Gonzalez, L., Li, D., Basso, J., Paget, C., Viaud-Massuard, M.-C., Lalmanach, G., Shi, G.-P., Aghdassi, A., Vlahou, A., … Korkmaz, B. (2024). Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases). Biochemical Pharmacology, 229, 116114. https://doi.org/10.1016/j.bcp.2024.116114

Chicago

Domain, Roxane, Seda Seren, Uwe Jerke, Manousos Makridakis, Kuan-Ju Chen, Jérôme Zoidakis, Moez Rhimi, et al. 2024. “Pharmacological Inhibition of Cathepsin S and of NSPs-AAP-1 (a Novel, Alternative Protease Driving the Activation of Neutrophil Serine Proteases).” Biochemical Pharmacology 229 (November): 116114. doi:10.1016/j.bcp.2024.116114.